Gardenia fruit compound starting point for diabetes therapy ( A Gardenia fruit extract traditionally ...)

Gardenia fruit compound starting point for diabetes therapy

A Gardenia fruit extract traditionally used in Chinese medicine to treat the symptoms of type 2 diabetes does indeed contain a chemical that reverses some of the pancreatic dysfunctions that underlie the disease, researchers report in the June 7, 2006, Cell Metabolism. The chemical therefore represents a useful starting point for new diabetes therapies, they said.

Such a drug could offer a big advance, the group added, as no currently available therapy for diabetes actually targets the underlying causes of disease in insulin-producing pancreatic beta cells. Insulin controls blood levels of glucose, the body's main energy source. In those with diabetes, insulin deficiency or insulin resistance causes blood sugar concentrations to rise.

The team discovered that Gardenia extract contains the chemical "genipin." Previously known for its ability to cross-link proteins, they now find that the chemical also blocks the function of the enzyme called uncoupling protein 2 (UCP2) through another mechanism. In both animals and humans, high concentrations of UCP2 appear to inhibit insulin secretion from the pancreas and increase the risk of type 2 diabetes.

"We think the increase in UCP2 activity is an important component of the pathogenesis of diabetes," said Bradford Lowell of Beth Israel Deaconess Medical Center and Harvard Medical School. "Our goal therefore was to discover a UCP2 inhibitor capable of working in intact cells, as such an inhibitor could theoretically represent a lead compound for agents aimed at improving beta cell function in type 2 diabetes."

Study coauthor Chen-Yu Zhang's familiarity with traditional Chinese medicine led the team to consider the extract of Gardenia jasminoides Ellis fruits. Pancreas cells taken from normal mice secreted insulin when treated with the extract, they found, whereas the cells of mice lacking UCP2 did not. The results suggested that the extract worked through its effects on the UCP2 enzyme.

'"/>

Source:Cell Press

Page: 1 2
Related biology news :

1. Master gene controls healing of skin in fruit flies and mammals
2. UI researcher studies deafness in fruit flies, humans
3. Gap-climbing fruit flies reveal components of goal-driven behaviors
4. Hormones and growth: The control of body size and developmental growth rate in fruit flies
5. Aloe vera coating may prolong freshness, safety of fruits and vegetables
6. Hanging baskets of sex and death help fruit growers
7. Researchers find gland that tells fruit flies when to stop growing
8. Past experience of pheromones induces dominant courtship behavior in fruit flies
9. A resetting signal keeps circadian rhythm on track in Drosophila fruit flies
10. Drunken elephants: The marula fruit myth
11. UCSD study finds anthrax toxins also harmful to fruit flies

Post Your Comments:

(Date:12/11/2009)... degrade the diverse types of defective proteins and thus ... C. Horn, Professor Thomas Sommer, Professor Udo Heinemann and ... Molecular Medicine (MDC) Berlin-Buch, Germany, have now found a ... that plays a critical role in the quality control ... and disposal of various defectively produced proteins. ( Molecular ...

(Date:12/11/2009)... the 4th edition of Springer,s classic reference and textbook ... Victor A. McKusick Leadership Award. The prize, which recognizes ... genetics, was presented to him at the 59th Annual ... 24 October 2009 in Honolulu, Hawaii. , Motulsky is ... University of Washington in Seattle. One of the founding ...

(Date:12/11/2009)... release is available in German . ... to more plant introductions than extinctions, plant communities ... The same species are occurring more frequently, whereas ... only the biological communities that are becoming increasingly ... These processes have led to a loss of ...

[0] MDC researchers identify a scaffold regulating protein disposal [0] Editor of Springer classic human genetics reference receives prize [0] Europe's flora is becoming impoverished

... than once, according to research published this week by Queen ... the ability to echolocate do not all group together in ... to their non-echolocating cousins, the fruit bats. This has raised ... than once, or whether the fruit bats somehow lost their ...

... Scientists at the M.D. Anderson Cancer Center have ... for African Americans that suggests a greater risk from ... published in the September issue of Cancer Prevention ... Cancer Research. , Etzel and colleagues analyzed data ...

... and industries around the world will collaborate on ... to develop implantable devices made from biodegradable metals. ... physical changes in a patient,s body and dissolve ... stents, and other devices would reduce the follow-up ...

Other Biology News:Molecular evolution is echoed in bat ears 2 African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease 2 Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 2 Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 3 Project aims to reduce complications, multiple surgeries with biodegradable implantable devices 4

Molecular evolution is echoed in bat ears African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease Project aims to reduce complications, multiple surgeries with biodegradable implantable devices

(Date:12/14/2009)... Decision Resources, one of the world,s ... healthcare issues, finds that, owing to the launches ... market will increase more than sevenfold from $790 ... in the United States, France, Germany, Italy, Spain, ... Pharmacor report entitled Atrial Fibrillation finds ...

(Date:12/14/2009)... -- , - Results From a ... Arthritis in Seven Major Industrialized Countries , , ... say their disease, impacts their ... living with rheumatoid arthritis find shopping for gifts, ... presents most, difficult to do, ...

(Date:12/11/2009)... 11 Dendreon Corporation (Nasdaq: DNDN ... previously announced public offering have exercised in full ... of common stock at the public offering price ... the option increases the size of the offering ... stock. Dendreon expects to receive net proceeds ...

(Date:12/11/2009)... have discovered a new explanation for differences in the severity ... a certain gene, the more serious the handicap. The genetic ... that it is the amount of copies of the GDI1 ... the American Journal of Human Genetics , and are ... connected to VIB, a life sciences research institute in Flanders, ...

Breaking Biology Technology:The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 2 Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 2 Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 3 Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas 4 Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2 Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3 Amount of gene surplus determines severity of mental retardation in males 2

[0] The Atrial Fibrillation Drug Market Will Increase More Than Sevenfold, from $790 Million in 2008 to $6.1 Billion in 2018 [0] Rheumatoid Arthritis Patients Want Pain-Free Days at Christmas [0] Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering [0] Amount of gene surplus determines severity of mental retardation in males

... for Lead Discovery, COPENHAGEN, June 18 ... a drug discovery collaboration with Merck & Co.,Inc., ... discovery,technology to identify novel small molecule leads against ... platform uses innovative DNA,labeling to allow fragment-based drug ...

... EAST HARTFORD, Conn., June 17 The Connecticut,Technology ... awards program in,partnership with accounting firm UHY LLP this ... Connecticut. Companies will be,recognized on the basis of revenue ... of $50,000 and minimum revenues of $3 million in,the ...

... 17 Edwards Lifesciences,Corporation (NYSE: EW ), ... advanced cardiovascular disease, is scheduled to participate in ... White Elephant,Hotel in Nantucket, Massachusetts on Tuesday, June ... corporate vice president, chief,financial officer & treasurer, is ...

Other Biology Technology:Nuevolution Announces Research and Development Collaboration with Merck & Co. Inc. 2 Connecticut Technology Council to Recognize Fast Growing Technology Companies 2 Edwards Lifesciences to Present at the 18th Annual Wachovia Nantucket Equity Conference 2

Nuevolution Announces Research and Development Collaboration with Merck & Co. Inc.Connecticut Technology Council to Recognize Fast Growing Technology Companies Edwards Lifesciences to Present at the 18th Annual Wachovia Nantucket Equity Conference

... the Moticam 2300 camera (MC2300) attaches to ... or trinocular port. Included in the standard ... 2.0ML software offers quick and accurate image ... resolution for examination or documentation purposes. The ...

... an aqueous solution that contains a purified ... a PBS buffer (phosphate buffered saline), pH ... not contain a preservative. StabilCoat Immunoassay ... dried protein components in immunoassays and can ...

Mouse monoclonal antibody to PARK2 - Parkinson disease (autosomal recessive, juvenile) 2, parkin...

Rabbit polyclonal antibody to NMDA NR2B [Tyr1336]...

Biology Products:

Moticam 2300 from Motic Instruments, Inc.StabilCoat Immunoassay Stabilizer from SurModics, Inc.Mouse Anti-Human PARK2 Monoclonal Antibody, Unconjugated, Clone 1H4 from Novus Biologicals Rabbit Anti-NMDA NR2B, phospho (Tyr1336) Polyclonal Antibody, Unconjugated from Novus Biologicals

( A Gardenia fruit extract traditionally ...)Gardenia fruit compound starting point for diabetes therapy